LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · IEX Real-Time Price · USD
2.740
-0.240 (-8.05%)
At close: Apr 24, 2024, 4:00 PM
2.750
+0.010 (0.36%)
After-hours: Apr 24, 2024, 7:22 PM EDT
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $72.03 million as of April 25, 2024. Its market cap has increased by 44.35% in one year.
Market Cap
72.03M
Enterprise Value
-23.66M
1-Year Change
44.35%
Ranking
Category
Stock Price
$2.74
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $72.03M, a decrease of -81.06%. That is a compound annual growth rate of -41.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 78.30M | 4.54% |
Apr 22, 2024 | 74.90M | 5.20% |
Apr 19, 2024 | 71.20M | -4.30% |
Apr 18, 2024 | 74.40M | -3.75% |
Apr 17, 2024 | 77.30M | 1.71% |
Apr 16, 2024 | 76.00M | -1.30% |
Apr 15, 2024 | 77.00M | -6.44% |
Apr 12, 2024 | 82.30M | -6.26% |
Apr 11, 2024 | 87.80M | 9.89% |
Apr 10, 2024 | 79.90M | 12.22% |
Apr 9, 2024 | 71.20M | -8.25% |
Apr 8, 2024 | 77.60M | -3.24% |
Apr 5, 2024 | 80.20M | 6.37% |
Apr 4, 2024 | 75.40M | -7.82% |
Apr 3, 2024 | 81.80M | -0.24% |
Apr 2, 2024 | 82.00M | -7.45% |
Apr 1, 2024 | 88.60M | 1.26% |
Mar 28, 2024 | 87.50M | -14.88% |
Mar 27, 2024 | 102.80M | -2.93% |
Mar 26, 2024 | 105.90M | 8.62% |
Mar 25, 2024 | 97.50M | 1.56% |
Mar 22, 2024 | 96.00M | 12.41% |
Mar 21, 2024 | 85.40M | 5.82% |
Mar 20, 2024 | 80.70M | -3.81% |
Mar 19, 2024 | 83.90M | 8.54% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Oncolytics Biotech | 79.94M |
CEL-SCI | 79.35M |
Entera Bio | 78.77M |
Marinus Pharmaceuticals | 78.69M |
Gritstone bio | 78.59M |
Athira Pharma | 78.19M |
Cognition Therapeutics | 78.00M |
Tiziana Life Sciences | 77.96M |